Key Highlights
- Rocket Lab (NASDAQ:RKLB) reported record third-quarter 2026 Revenue of USD 267.8 million on November 9, up 73% from a year earlier and above its own forecast of USD 250 million to USD 265 million.
- Backlog rose 52% in one quarter to USD 3.57 billion from USD 2.36 billion at the end of June, with nearly USD 1 billion of new launch contracts signed.
- The shares fell about 6.7% to USD 54.94 in after-hours trading, after closing the regular session up 10.9% at USD 58.86.
- The company confirmed that its Neutron rocket will not fly before 2027 and reported a net loss of USD 79.7 million, or USD 0.12 per share.
Strong Growth Across Both Segments
The quarter showed a Business scaling quickly. Space Systems revenue, which covers satellites, components and spacecraft, rose 88% to USD 214.8 million. Launch Services revenue rose 30% to USD 53.1 million on six Electron missions, compared with four a year earlier. Adjusted gross Margin was 38.4%, above the 35% to 37% guided, though below 41.9% a year earlier. Adjusted EBITDA was a loss of USD 18.0 million, within guidance, and Operating Cash Flow turned positive at USD 7.2 million, the first positive quarter in five. The company ended with about USD 4.45 billion of cash. Fourth-quarter guidance calls for revenue of USD 270 million to USD 290 million and adjusted gross margin of 39% to 41%, which would mark another record. Revenue per Electron launch was USD 7.8 million, down from USD 10.1 million, reflecting mission mix.
Why the Stock Fell
The selloff reflects timing and cost rather than demand. Neutron, the medium-lift reusable rocket central to Rocket Lab's long-term valuation, was delayed in October after a defect was found in a carbon composite fuel tank dome. Chief executive Peter Beck declined to give a new date "until that tank is through the gauntlet of all of its testing." Operating expenses of USD 169.3 million ran above the USD 143 million to USD 149 million guided, and the net loss widened, partly because of a USD 27.3 million charge from cancelling a USD 3.6 billion bridge Loan linked to the pending Iridium acquisition. The share of Backlog due within 12 months fell to about 33% from 45%, pushing revenue further out. The stock had also rallied strongly into the report, leaving room for profit-taking.
Neutron Demand and the NASA Setback
Demand for Neutron is building even before its first flight. Rocket Lab signed eight Neutron launches in the quarter, worth more than USD 515 million, and raised its base price to USD 70 million from USD 55 million. Customers include ICEYE, Muon Space, Starcloud, Kepler and the US Space Force. On the same weekend, however, NASA selected eight companies for a USD 10 billion lunar delivery program, and Rocket Lab was not among them. That limits one potential growth avenue in the near term, although the company remains a major supplier of spacecraft and components. Investors will watch Neutron test milestones, conversion of the larger backlog and progress on the Iridium deal, which requires regulatory approvals and is expected to close in 2027. Neutron is designed to carry up to 13,000 kilograms to low Earth orbit, which would put Rocket Lab in direct competition for the constellation launch market.
Where Things Stand
Rocket Lab delivered record revenue, a 52% jump in backlog and positive operating cash flow, but the shares fell about 6.7% after hours because Neutron's first launch has slipped into 2027, costs ran above plan and the stock had rallied 10.9% earlier in the day. Fourth-quarter guidance points to another record. Neutron testing updates are now the main catalyst for the stock.
_11_17_2026_20_20_39_897848.jpg)

_11_17_2026_20_22_32_846230.jpg)



Please wait processing your request...